Janux Partners With Merck

BIOTECH: Deal Worth More Than $1 Billion

By FRED GRIER
FRONT PAGE

Merck has entered an agreement with San Diego-based biotech Janux Therapeutics in a deal valued at more than $1 billion. The pair will team up on two cancer targets selected by Merck, with Janux eligible for up to $500.5 million in upfront and...

Read latest San Diego Business Journal online.

Online newspapers at PressDisplay.